Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
29 Cards in this Set
- Front
- Back
How are hypothalamic hormones released and regulated?
|
released in a rhythmic/circadian pattern and regulated in a negative feedback loop.
|
|
What are the hormones released from the hypothalamus?
|
TRH; CRH; GnRH; GHRH; somatostatin; dopamine
|
|
What are the hormones released from the anterior pituitary that are stimulated by the hypothalamus?
|
TSH; ACTH; FSH/LH; GH
|
|
What target organs and hormones are stimulated by the anterior pituitary?
|
Thyroxine & T3 from thyroid
glucocorticoid from adrenals androgens, estrogens & progestins from gonads IGF-1 from liver |
|
what is the function of somatostatin?
|
To inhibit GH release from the anterior pituitary.
|
|
what is the function of dopamine?
|
Inhibits prolactin release.
|
|
Growth Hormone production
|
most abundant hormone in AP.
1 gene produces a heterogenous mix of peptides, leads to several GH's of different AA combos. |
|
Growth Hormone control and release
|
controlled Somatostatin and GHRH
Released by nurons in hypothalamus in pulsatile fashion therfore pulsatile stimulation of somatrophs in AP which release GH. |
|
Somatostatin receptors
|
there are up to 5 SS receptors: SSTR2 and SSTR5 are the most important
|
|
Somatostatin
|
Decapeptide, inhibits GH, made in hypothalamus and pancreatic islets, also inhibits TSH, gonadotropins, insulin and glucagon release
|
|
GH Regulation
|
Negative Feedback loop
short loop- GH feedback to neurons of GnRH, inhibits GHRH's release classic loop- end hormone (IGF-1)inhibits GH release of GHRH release |
|
What influences GH secretion?
|
sleep, hypoglucemia, physical exertion, emotional excitement, drugs: increased by alpha agonists, L-dopa and amphetamines; decreased by Beta agonists and phenothiazines
|
|
What is the insulin tolerance test?
|
hypoclycemia increases GH release. Test: infuse insulin, blood gluc should dec, GH should inc, and cortisol should inc.
|
|
pharmocodynamics of GH
|
GH binds to cell surface receptors, and also circulates bound to extracellular protein domain of GH receptors
|
|
Function of GH alone
|
GH directly increases lipolysis and gluconeogenesis
|
|
Function of GH through IGF-1
|
anabolic and growth promoting effects (metab of proteins, fat, carbs, Ca) results in growth(increased cell number not size)
|
|
Function of IGF's
|
mediate most GH effects
IGF-2 activates intracellular mannose-6-phosphate receptor IGF-1 binds receptors similar to insulin receptor |
|
Diseases of hypo GH secretion.
|
dwarfism- in children
endocrinopathies in adults (including increased cardiovascular mortalities) |
|
Diseases of hyper GH secretion.
|
Gigantism- in kids before epiphyseal plates close
acromegaly- after plates close |
|
symptoms of acromegaly
|
visual problems from pituitary adenomas, bone overegrowth in hands, feet and face, headaches, sweating, diabetes, joint problems, colon cancer, cardiovascular disease
|
|
prolactin
|
structurally related to GH
secretion influenced by same factors as GH plus estrogen role= lactation receptors on other cells have unknown functions |
|
hyperprolactemia
|
suppresses HPG-axis through actions on hypothalamus and gonads
Treatment= dopamine, bromocriptine, pergolide, cabergoline |
|
Octreotide
|
SS analog,treats acromegaly, preferred because most specific for GH system, has modified Amino acid therefore longer t1/2 & greater selectivity,also used for metastatic carcinoid cancers, VIP secreting tumors, AIDS related diarrhea; SIDE EFFECTS: hypothyroidism, GI symptoms (loose stool, malabsorption, nausea and flatulence)
|
|
Pegvisomant
|
GH receptor antagonist, genetically engineered analog of human GH conjugated to polyethylene glycol= pegylation (reduces renal clearance and gives longer t1/2)
mech: blocks GH binding to receptor therefore decreases serum IGF-1 secretion but increases GH in serum most effective for acromegegaly SE: can develop auto GH Ab's leads to CV probs |
|
Bromocriptine
|
dopamine agonist, treats acromegaly, hyperprolactinemia, amenorrhea, galactoffhea, infertility, hypogonadism, parkinson's; SE= HA, dizziness, nausea, HTN, postural hypotension, contraindicated in pts with sensitivity to ergot alkaloids
|
|
Growth Hormone as a drug
|
for dwarfism, chronic renal insufficiency, Turner's syndrome; can be prepared as hGH (somatropin)(encapsulated for monthly IM injections)or synthetic hGH with methionine removed (somatotrem)
|
|
Dopamine
|
inhibits prolactin release
|
|
pergolide
|
for hyperprolactinemia,
|
|
cabergoline
|
longer t1/2, more potent D2 selective, used once or twice a week
preferred over bromcriptine in acromegaly |